COUCHBASE INC (BASE)

US22207T1016 - Common Stock

16.425  -4.69 (-22.23%)

Fundamental Rating

4

BASE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the IT Services industry. No worries on liquidiy or solvency for BASE as it has an excellent financial health rating, but there are worries on the profitability. BASE is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

BASE had negative earnings in the past year.
BASE had a negative operating cash flow in the past year.
In the past 5 years BASE always reported negative net income.
BASE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of BASE (-33.29%) is worse than 82.72% of its industry peers.
BASE's Return On Equity of -62.02% is on the low side compared to the rest of the industry. BASE is outperformed by 75.31% of its industry peers.
Industry RankSector Rank
ROA -33.29%
ROE -62.02%
ROIC N/A
ROA(3y)-27.17%
ROA(5y)-32.49%
ROE(3y)-46.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BASE has a Gross Margin of 88.74%. This is amongst the best in the industry. BASE outperforms 98.77% of its industry peers.
In the last couple of years the Gross Margin of BASE has remained more or less at the same level.
BASE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

BASE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BASE has more shares outstanding
BASE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

BASE has an Altman-Z score of 3.07. This indicates that BASE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.07, BASE is in line with its industry, outperforming 53.09% of the companies in the same industry.
There is no outstanding debt for BASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.07
ROIC/WACCN/A
WACC11.35%

2.3 Liquidity

BASE has a Current Ratio of 1.97. This is a normal value and indicates that BASE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.97, BASE is doing good in the industry, outperforming 62.96% of the companies in the same industry.
A Quick Ratio of 1.97 indicates that BASE should not have too much problems paying its short term obligations.
BASE has a Quick ratio of 1.97. This is in the better half of the industry: BASE outperforms 62.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.97

7

3. Growth

3.1 Past

BASE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.43%, which is quite impressive.
BASE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.30%.
The Revenue has been growing by 20.34% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)61.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)16.3%
Revenue growth 3Y20.34%
Revenue growth 5YN/A
Sales Q2Q%12.7%

3.2 Future

BASE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.64% yearly.
The Revenue is expected to grow by 20.73% on average over the next years. This is a very strong growth
EPS Next Y41.6%
EPS Next 2Y31.23%
EPS Next 3Y28.64%
EPS Next 5YN/A
Revenue Next Year17.59%
Revenue Next 2Y16.37%
Revenue Next 3Y16.66%
Revenue Next 5Y20.73%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BASE. In the last year negative earnings were reported.
Also next year BASE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BASE's earnings are expected to grow with 28.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.23%
EPS Next 3Y28.64%

0

5. Dividend

5.1 Amount

No dividends for BASE!.
Industry RankSector Rank
Dividend Yield N/A

COUCHBASE INC

NASDAQ:BASE (12/4/2024, 3:35:05 PM)

16.425

-4.69 (-22.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap842.93M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.29%
ROE -62.02%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 88.74%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.97
Quick Ratio 1.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)61.43%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y41.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.3%
Revenue growth 3Y20.34%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y